¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"suppressor area"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suppressor area
    ¾ïÁ¦±¸¿ª
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • extragenic suppressor mutation
    À¯ÀüÀڿܹßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
  • suppressor
    ¾ïÁ¦ÀÎÀÚ
  • suppressor cell
    ¾ïÁ¦¼¼Æ÷
  • suppressor gene
    ¾ïÁ¦À¯ÀüÀÚ
  • suppressor mutation
    ¾ïÁ¦(µ¹¿¬)º¯ÀÌ
  • suppressor T cell
    ¾ïÁ¦T¼¼Æ÷
  • apical area
    Ä¡±Ù÷´ÜºÎ
  • arcuate area
    Ȱ²Ã±¸¿ª
  • area
    1. ±¸¿ª, ¿µ¿ª, ¿ª 2. ºÎÀ§, ºÎ 3. ¸éÀû
  • area cerebrovasculosa
    ³úÇ÷°ü´õ¹Ì
  • area cribrosa
    ü±¸¿ª
  • area monitoring
    ±¸¿ª°¨½Ã
  • area paraterminalis
    Á¾¸»ÆÇ¿·±¸¿ª
  • area pellucida
    Åõ¸í±¸¿ª
  • area postrema
    ¸Ç¾Æ·¡±¸¿ª
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • tumor suppressor gene
    Á¾¾ç¾ïÁ¦À¯ÀüÀÚ
  • suppressor
    ¾ïÁ¦ÀÎÀÚ
  • area
    ±¸¿ª, ¿µ¿ª, ¿ª, ºÎÀ§, ºÎ, ¸éÀû
  • area cribrosa
    ü±¸¿ª
  • area postrema
    ¸Ç¾Æ·¡±¸¿ª
  • inguinal area
    »ô±¼ºÎÀ§, ¼­ÇýºÎ
  • preoptic area
    ½Ã°¢±³Â÷¾Õ±¸¿ª
  • subareolar area
    Á¥²ÉÆÇ¹ØºÎÀ§, À¯·ûÇϺÎ
  • supporting area
    ÁöÁöºÎ
  • surface area
    üǥ¸éÀû, Ç¥¸éÀû
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suppressor area
    ¾ïÁ¦±¸¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • crossing-over suppressor
    ±³Â÷¾ïÁ¦ÀÎÀÚ
  • suppressor cell
    ¾ïÁ¦¼¼Æ÷
  • suppressor T cell
    ¾ïÁ¦Æ¼¼¼Æ÷
  • extragenic suppressor mutation
    À¯ÀüÀڿܹßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
  • tumor suppressor gene
    Á¾¾ç¾ïÁ¦À¯ÀüÀÚ
  • suppressor
    ¾ïÁ¦ÀÎÀÚ
  • soluble immune response suppressor
    °¡¿ë¸é¿ª¹ÝÀÀ¾ïÁ¦ÀÎÀÚ
  • suppressor strip
    Á¦Áö¶ì
  • area
    ±¸¿ª, ¿µ¿ª, ¿ª, ºÎ, ¸éÀû
  • area cerebrovasculosa
    ³úÇ÷°ü±¸¿ª
  • area cribrosa
    ü±¸¿ª
  • area paraterminalis
    Á¾¸»ÆÇ¿·±¸¿ª
  • area pellucida
    Åõ¸í±¸¿ª
  • area postrema
    ¸Ç¾Æ·¡±¸¿ª
  • absorbing area
    Èí¼ö±¸¿ª
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-idiotypic T suppressor cell
    Ç×°³º°Æ¯ÀÌÇü ¾ïÁ¦T¼¼Æ÷
  • gene, suppressor
    ¹ßÇö¾ïÁ¦À¯ÀüÀÚ
  • AUC : area under the concentration-time curve
    Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
  • Brocas area
    ºê·ÎÄ«¿µ¿ª.
  • Brocas area
    ºê·ÎÄ«¿µ¿ª
  • Brocas speech area
    ºê·ÎÄ«¾ð¾î¿µ¿ª
  • Brodmanns area
    ºê·Îµå¸¸ ¿µ¿ª(çÐæ´)
  • Frontal association area
    ÀüµÎ¿¬ÇÕ¾ß(îñÔéÖ¤ùêå¯)
  • Kiesselbachs area
    ºñÁß°ÝÀüÇϹæºÎÀ§, Ű¼¿¹ÙÇϺÎÀ§
  • LAN (local area network)
    ±Ù°Å¸® Åë½Å¸Á, ·£
  • Limbic association area
    º¯¿¬°ü·Ã¿µ¿ª(Ü«æÞμ֤ÖÅæ´)
  • Littles area =Kiesselhachs plexus
    ºñÁß°ÝÀüÇϹæÇ÷°üÃÑ, ¸®Æ²ºÎÀ§
  • Pannums fusion area
    ÆÄ´®À¶ÇÕ¿ª
  • REM-sleep-promoting area
    ·½¼ö¸éÁõÁø¿µ¿ª
  • WAN (wide area network)
    ±¤¿ª Åë½Å¸Á
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suppressor area
    ¾ïÁ¦¿µ¿ª.
  • suppressor area
    ¾ïÁ¦¿µ¿ª
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cochlear area, =area cochleae <³ª>
    ¿Í¿ì¿µ¿ª, ´ÞÆØÀ̽Ű汸¿ª{ÇØ}
  • cochlear area<³ª> area cochleae
    ´ÞÆØÀ̽Ű汸¿ª, ¿Í¿ì¾ß(èÄéÚå¯).
  • supplemental motor area = supplementary area
    º¸Á¶¿îµ¿¿µ¿ª(ÜÍð¾ê¡ÔÑçÐæ´)
  • anti-idiotypic T suppressor cell
    Ç×°³º°Æ¯ÀÌÇü ¾ïÁ¦T¼¼Æ÷
  • cancer suppressor genes
    ¾Ï¾ïÁ¦À¯ÀüÀÚ(äßåäð¤ë¶îîí­)
  • cell, suppressor T
    ¾ïÁ¦T¼¼Æ÷
  • crossing over suppressor
    ±³Â÷¾ï¾ÐÀÎÀÚ(¡­åääâì×í­).
  • cytotoxic/suppressor T cell
    ¼¼Æ÷µ¶¼º/¾ïÁ¦ T ¼¼Æ÷
  • gene, suppressor
    ¹ßÇö¾ïÁ¦À¯ÀüÀÚ
  • mutation, extragenic suppressor
    À¯ÀüÀÚ¿Ü ¹ßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
  • mutation, suppressor
    ¾ïÁ¦ µ¹¿¬º¯ÀÌ (¹ßÇö)
  • soluble immune response suppressor
    °¡¿ë¼º ¸é¿ª¹ÝÀÀ¾ïÁ¦ÀÎÀÚ
  • suppressor
    ¾ï¾ÐÀÚ, ¾ï¾ÏÀ¯ÀüÀÚ.
  • suppressor T cell
    ¾ïÁ¦ T ¼¼Æ÷
  • suppressor T cell
    ¾ïÁ¦T¼¼Æ÷, Á¦¾îT¼¼Æ÷.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Marginal area
    °¡ÀåÀÚ¸®±¸¿ª
    [¿¾ ¿ë¾î] º¯¿¬ºÎ
  • Cupula area
    ²À´ë±â±¸¿ª
    [¿¾ ¿ë¾î] ¹èºÎ
  • Subcallosal area
    ³úµéº¸¹Ø±¸¿ª
    [¿¾ ¿ë¾î] ¾çÇϾß
  • Cochlear area
    ´ÞÆØÀ̽Ű汸¿ª
    [¿¾ ¿ë¾î] ¿Í¿ì¾ß
  • Contact area
    ´ê´ÂºÎºÐ
    [¿¾ ¿ë¾î] Á¢Ã˸é
  • Posterior intercondylar area
    µÚÀ¶±â»çÀ̱¸¿ª
    [¿¾ ¿ë¾î] Èİú°£±¸
  • Area postrema
    ¸Ç¾Æ·¡±¸¿ª
    [¿¾ ¿ë¾î] ÃÖÇϾß
  • Bare area
    ¹«À帷±¸¿ª
    [¿¾ ¿ë¾î] ¹«À帷¾ß
  • Opaque area
    ºÒÅõ¸í±¸¿ª
    [¿¾ ¿ë¾î] ¾Ï¾ß[ºÎ]
  • Vesiclular area
    ¼ÒÆ÷±¸¿ª
    [¿¾ ¿ë¾î] ¼ÒÆ÷ºÎ
  • Preoptic area
    ½Ã°¢±³Â÷¾Õ±¸¿ª
    [¿¾ ¿ë¾î] ½Ã½Å°æ±³Â÷Àü¾ß
  • Cardiogenic area
    ½ÉÀå¹ß»ý±¸¿ª
    [¿¾ ¿ë¾î] ½ÉÀå¹ß»ý±¸¿ª
  • Inferior vestibular area
    ¾Æ·¡¾È¶ã½Å°æ±¸¿ª
    [¿¾ ¿ë¾î] ÇÏÀüÁ¤¾ß
  • Vestibular area
    ¾È¶ã±¸¿ª
    [¿¾ ¿ë¾î] ÀüÁ¤½Å°æ¾ß
  • Anterior intercondylar area
    ¾ÕÀ¶±â»çÀ̱¸¿ª
    [¿¾ ¿ë¾î] Àü°ú°£±¸
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperendemic area
    °íµµÀ¯ÇàÁö
  • hypoendemic area
    ÀúµµÀ¯ÇàÁö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximum height-area method
    Ãִ뱤¿ª¹ý(õÌÓÞÎÆæ´Ûö)
  • intergenic suppressor mutation
    À¯ÀüÀÚ°£ ¾ï¾ÐÀÚº¯ÀÌ(ë¶îîí­Êàåääâí­Ü¨ì¶)
  • nonsense suppressor
    ³Í¼¾½º ¾ï¾ÐÀÚ(åääâí­)
  • suppressor
    "¾ï¾ÐÀÚ (åääâí­), ¾ï¾ÐÀ¯ÀüÀÚ(åääâë¶îîí­)"
  • suppressor factors
    ¾ï¾Ð(ÀÚ) ÀÎÀÚ(åääâ(í­)ì×í­)
  • suppressor gene
    ¾ï¾Ð(ÀÚ)À¯ÀüÀÚ(åääâ(í­)ë¶îîí­)
  • suppressor mutation
    ¾ï¾Ð(ÀÚ)º¯ÀÌ(åääâ(í­)ܨì¶)
  • suppressor-sensitive mutant
    ¾ï¾Ð(ÀÚ)°¨¼ö º¯ÀÌÁÖ(åääâ(í­)Êïáôܨì¶ñ»)
  • suppressor T cell
    ¾ï¾Ð(åääâ) T ¼¼Æ÷(á¬øà)
  • suppressor transfer RNA
    ¾ï¾Ð(åääâ) Àü´Þ(îîÓ¹) RNA
  • T suppressor cell
    T ¾ï¾Ð¼¼Æ÷(åääâá¬øà)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suppressor grid
    ¾ïÁ¦°ÝÀÚ
  • adjacent area
    ÀÎÁ¢¿ª
  • area
    ¿µ¿ª, ¾ß, Áö¿ª, ±¸
  • bare area
    ³ëÃâºÎ
  • Broca's area
    ºê·ÎÄ«¿µ¿ª
  • high echo area
    °í¿¡ÄÚ ±¸¿ª
  • LAN [=local area network]
    ±Ù°Å¸®Åë½Å¸Á, ·£
  • Lor-fitted area
    Ãִ뿵¿ª
  • low echo area
    Àú¿¡ÄÚ±¸¿ª
  • motor speech area
    ¿îµ¿¾ð¾î·É
  • postcricoid area
    À±»ó¿¬°ñÈĺÎ
  • posterior hypothalamic area
    ÈĽûóÇϺοµ¿ª
  • premotor area
    Àü¿îµ¿¿µ¿ª
  • saddle bag area
    ¸¸³²¸é
  • skip area
    °Ç³Ê¶Ú °÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AHA acetohydroxamic acid; acquired hemolytic anemia; acute hemolytic anemia; American Heart Association;...
IA ibotenic acid; immune adherence; immunoadsorbent; immunobiologic activity; impedance angle; indolami...
LA50 total body surface area of burn that will kill 50% of patients (lethal area)
Ts cell suppressor T cell(= T8 cell)
CD8 HIV suppressor cell count
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GSE genetic suppressor element
KSR Kinase Suppressor of Ras
MNSF Monoclonal non-specific suppressor factor
NS Natural suppressor
SIRS Soluble immune response suppressor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • suppressor area
    ¾ïÁ¦ ¿µ¿ª
    ¿îµ¿À» ¾ïÁ¦, ¹æÇØÇÏ´Â ´ë³ú ÇÇÁúÀÇ ¿µ¿ª.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cancer suppressor gene
    ¾Ï ¾ïÁ¦ À¯ÀüÀÚ
  • suppressor mutation
    ¾ïÁ¦ µ¹¿¬º¯ÀÌ
  • T-suppressor
    T ¾ï¾Ð
  • anesthetic area
    ¸¶Ãë ¿ª
  • anterior amygdaloid area
    ¾Õ Æíµµ ±¸¿ª
  • aortic area
    ´ëµ¿¸Æ ¸é
    ¿ìÃø Á¦ 2´Á¿¬°ñÀÇ ³»Ãø´ÜºÎ À§ÀÇ Èä°û Ç¥¸é.
  • apical area
    ±Ù÷ºÎ, Ä¡±Ù÷ºÎ, ±Ù÷´ÜºÎ, Ä¡±Ù ÷´ÜºÎ
  • area
    ¿µ¿ª, ¾ß, ±¸
    ±¹ÇÑµÈ ºÎºÐ. ƯÀÌÇÑ Ç¥¸é ºÎºÐ°ú ±â´É ºÎÀ§¸¦ Ç¥½ÃÇÏ´Â ÇØºÎÇÐ ¿ë¾î.
  • area centralis
    Áß½É¿Í ¿µ¿ª
    ¸Á¸·ÀÇ ½Å°æÀý ¼¼Æ÷Ãþ¿¡ ÀÖ´Â ¼Ò¿Í ÁÖÀ§ÀÇ ¼¼Æ÷ ¿µ¿ª.
  • area cochleae
    ¿Í¿ì ¿µ¿ª
    ¿Í¿ìÀúÀÇ ±Ù¹æ¿¡¼­ ³»À̵µÀú ÇϺÎÀÇ ¾ÕºÎºÐ.
  • area cribrosa
    ü±¸¿ª
  • area lunata
    ¿ù»ó ¿µ¿ª
    ¼Ò³ú ¹Ý±¸ÀÇ ÈĹݿù ¼Ò¿±À¸·Î¼­ ÈÄ¿ù¿±ÀÇ ¾Õ¿¡ ÀÖ´Ù.
  • area nervi facialis
    ¾È¸é ½Å°æ ¿µ¿ª
    ¾È¸é ½Å°æÀÌ ¾È¸é ½Å°æ °ü¿¡ µé¾î°¡´Â ³»À̵µÀúÀÇ ºÎºÐ.
  • area of body surface
    üǥ¸éÀû
  • area pellucida
    Åõ¸í ±¸¿ª, Åõ¸íºÎ
    »õÀÇ ¾Ë¿¡¼­ ³ªÅ¸³ª´Â ¹è¹Ý ¿Ü°ûÀÇ Åõ¸íÇÑ ºÎºÐ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
amber suppressor <molecular biology> A tRNA molecule which suppresses amber mutations because it has mutated to recognise the amber codon UAG (which normally signals that the translation of mRNA into an amino acid chain should stop) as a signal for inserting whatever amino acid it carries into the chain. As a result, it can prevent the amino acid chain from ending before it is completed.
(09 Oct 1997)
genes, suppressor Genes that inhibit expression of a previous mutation. They allow the wild-type phenotype to be wholly or partially restored.
(12 Dec 1998)
genes, suppressor, tumour Genes that inhibit expression of the tumourigenic phenotype. They are normally involved in holding cellular growth in check. When tumour suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and deregulated growth is possible.
(12 Dec 1998)
suppressor A compound that suppresses the effects of mutation or suppresses what would be a normal course of events.
(05 Mar 2000)
suppressor cell <immunology> Lymphocyte class of cells suppressing T or B antigen dependent responses.
(18 Nov 1997)
suppressor cells Cells of the immune system that inhibit or help to terminate an immune response, e.g., suppressor macrophages and suppressor T-cells.
Synonym: cytotoxic cell.
(05 Mar 2000)
suppressor factor <immunology> Factors released by T suppressor cells.
See: suppressor mutation, ochre suppressor, opal suppressor.
(19 Jan 1998)
suppressor factors, immunologic Proteins, protein complexes, or glycoproteins secreted by suppressor T-cells that inhibit either subsequent T-cells, B-cells, or other immunologic phenomena. Some of these factors have both histocompatibility (I-j) and antigen-specific domains which may be linked by disulfide bridges. They can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory.
(12 Dec 1998)
suppressor mutation <molecular biology> Mutation that alleviates the effect of a primary mutation at a different locus.
May be through almost any mechanism that can give a primary mutation, but perhaps the most interesting class are the amber and ochre supressors, where the anticodon of the tRNA is altered so that it mis reads the termination codon and inserts an amino acid, preventing premature termination of the peptide chain.
(18 Nov 1997)
suppressor-sensitive mutant A conditionally lethal, host range, bacteriophage mutant that produces nonsense codons and can replicate only in a host bacterium able to translate the nonsense codon; the mutation's effects are lethal (i.e., prevent replication of the virus) in a bacterium without such a suppressor mechanism.
(05 Mar 2000)
suppressor T-cell <immunology> See T-cells.
(18 Nov 1997)
suppressor tRNA The tRNA associated with a suppressor mutation.
(05 Mar 2000)
ochre suppressor A gene that codes for an altered tRNA so that its anticodon can recognise the ochre codon and thus allows the continuation of protein synthesis. A suppressor of an ochre mutation is a tRNA that is charged with the amino acid corresponding to the original codon or a neutral substitute. Ochre suppressors will also suppress amber codons.
(18 Nov 1997)
opal suppressor <molecular biology> A gene that codes for an altered tRNA so that its anticodon can recognise the opal codon and thus allows the continuation of protein synthesis. A suppressor of an opal mutation is a tRNA that is charged with the amino acid corresponding to the original codon or a neutral substitute. Some eukaryote cells normally synthesise opal suppressor tRNAs. The function of these is not clear and they usually do not prevent normal termination of protein synthesis at an opal codon.
(18 Nov 1997)
T-lymphocytes, suppressor-effector Subpopulation of CD8+ T-lymphocytes which suppress antibody production or inhibit cellular immune responses. Suppressor-effector cells execute the message received from suppressor-inducer cells (T-lymphocytes, suppressor-inducer).
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suppressor
    Áø¾ÐÀÚ;¾ïÁ¦ÀÚ;ÀºÆóÀÚ;±ÝÁöÀÚ
  • suppressor grid
    ¾ïÁ¦ ±×¸®µå
  • area
    ¸éÀû,Áö¿ª
  • Special Area
    Ưº°Áö±¸
  • area
    ¸éÀû;°ø°£;Áö¿ª;Áö¹æ;¿µ¿ª;°øÁö;¹üÀ§;ÁöÇÏ½Ç ÃâÀÔ±¸
  • area code
    ½Ã¿Ü±¹¹ø(¹Ì±¹Àº ¼ýÀÚ 3ÀÚ¸®)
  • blanket area
    (¹æ¼Û±¹ ÁÖº¯ÀÇ)³­Ã»±¸¿ª
  • catchment area (basin)
    (°­.¸øÀÇ) Áý¼ö Áö¿ª;(Çб³.º´¿ø.°üû µîÀÇ)´ã´ç(°üÇÒ)±¸¿ª
  • corps area
    ±º´Ü ÀÛÀü Áö¿ª;±º°ü±¸ 
  • culture area
    (°øÅëÀÇ)¹®È­ ¿µ¿ª
  • depressed area
    ºÒȲÁö¿ª(Áö¹æ)
  • development area
    »ê¾÷ °³¹ß Áö±¸
  • disaster area
    (¹Ì)ÀçÇØ Áö¿ª;(ÀçÇØ±¸Á¶¹ýÀÌ Àû¿ëµÇ´Â)ºñ»ó ÀçÇØ Áö±¸
  • distressed area
    ÀçÇØ Áö±¸;ºó¹Î Áö±¸
  • dollar area
    (°æ)´Þ·¯ Áö¿ª
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á